Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Our Vision

Our vision is to transform research and healthcare in dementia. Dementia Research Oxford, led by Professors Masud Husain and Cornelia van Duijn, brings together researchers and clinicians across the University, our hospitals, patients, and industry partners to translate our growing insights in the basic molecular origin disease into effective treatment and prevention. We aim to take science further from drug target to treatment, from molecular pathology to early diagnosis and prognosis and from early intervention to prevention.

From drug target to treatment

Combining our powerful chemistry with PET imaging provides the potential to monitor how drugs interact with their targets in the brain to improve development of new therapies.

From molecular pathology to early diagnosis and prognosis

Using state of the art molecular research and big data analysis allows us to improve early diagnosis and monitor disease process long before the onset of dementia.


Based our renowned clinical trial centre and world class clinical and preventive trial expertise, our ambition is to move new potential drugs and life style interventions to the clinic and curb the epidemic of dementia.

Age-related genetic architecture of Alzheimer’s disease

Professor Valentina Escott-Price, Cardiff University, introduced by Professor John Gallacher

Disease Areas

Our Dementia Research Oxford Teams